David Gallagher to head up IPHA
October 4, 2010Sales and Marketing IPHA, appointment, sales and marketing
Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …
Talking R&D: US regulatory guidelines
October 4, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD submissions
Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …
Zydus Nycomed’s API plant to start production soon
October 4, 2010Manufacturing and Production API, India, Nycomed, Zydus Cadila
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
AZ-BMS diabetes drug impresses in phase III trials
October 1, 2010Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes
AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …
FDA unveils new trial data rules
October 1, 2010Research and Development FDA, clinical trials, pharmacovigilance
The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …
BMS poaches AZ’s head of global medical affairs
October 1, 2010Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …
New digital agency Intensity launched
October 1, 2010Medical Communications Creston, Intensity, OnMedica, Pan, Red Door
Medical communications group Creston has launched a new digital specialist agency called Intensity Digital. The start-up agency aims to serve …
J&J chief admits mistakes at Congressional hearing
October 1, 2010Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …
Sanofi signs $2.2bn CRO deal
October 1, 2010Research and Development CRO, Covance, Sanofi-Aventis
Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …
The Food and Drug Administration (FDA)
October 1, 2010FDA, Food and Drug Administration
The current incarnation of the Food and Drug Administration (FDA) was established in 1930, but the US regulator’s modern functions …
National Institute for health and Clinical Excellence (NICE)
October 1, 2010NICE, National Institute for health and Clinical Excellence
The National Institute for health and Clinical Excellence (NICE) is a UK cost-effectiveness body that assesses a drug’s cost against …
Doctors express serious doubts about health reforms
October 1, 2010Sales and Marketing BMA, NHS, healthcare reform, reform
The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …
GPs urge more patient ‘self care’ for minor ailments
September 30, 2010Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime
Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …
Caelyx rights to revert back to Janssen
September 30, 2010Sales and Marketing Caelyx, Janssen, Merck
Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
New Herceptin data sways NICE
September 30, 2010Sales and Marketing Herceptin, NICE, Roche
NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …
Termeer exit could help Sanofi
September 30, 2010Sales and Marketing Genzyme, M&A, MA, Sanofi
Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …
Nestlé to pioneer ‘health science nutrition’
September 29, 2010Sales and Marketing Alzheimer's, health science nutrition, nestle
Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …
Europe votes for patients’ access to information
September 29, 2010Medical Communications, Sales and Marketing Europe, medicines information
Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …
ClinTec recruits former Wyeth VP
September 29, 2010Research and Development ClinTec, appointment, research and development
Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …
The FDA Interview: Is pharma getting worse at manufacturing?
September 29, 2010Manufacturing and Production, Research and Development FDA, manufacturing, manufacturing compliance
It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
